Suppr超能文献

表皮通透屏障功能需要脂肪酸。

Fatty acids are required for epidermal permeability barrier function.

作者信息

Mao-Qiang M, Elias P M, Feingold K R

机构信息

Department of Dermatology, University of California, San Francisco 94143.

出版信息

J Clin Invest. 1993 Aug;92(2):791-8. doi: 10.1172/JCI116652.

Abstract

The permeability barrier is mediated by a mixture of ceramides, sterols, and free fatty acids arranged as extracellular lamellar bilayers in the stratum corneum. Whereas prior studies have shown that cholesterol and ceramides are required for normal barrier function, definitive evidence for the importance of nonessential fatty acids is not available. To determine whether epidermal fatty acid synthesis also is required for barrier homeostasis, we applied 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA), an inhibitor of acetyl CoA carboxylase, after disruption of the barrier by acetone or tape stripping. TOFA inhibits epidermal fatty acid by approximately 50% and significantly delays barrier recovery. Moreover, coadministration of palmitate with TOFA normalizes barrier recovery, indicating that the delay is due to a deficiency in bulk fatty acids. Furthermore, TOFA treatment also delays the return of lipids to the stratum corneum and results in abnormalities in the structure of lamellar bodies, the organelle which delivers lipid to the stratum corneum. In addition, the organization of secreted lamellar body material into lamellar bilayers within the stratum corneum interstices is disrupted by TOFA treatment. Finally, these abnormalities in lamellar body and stratum corneum membrane structure are corrected by coapplication of palmitate with TOFA. These results demonstrate a requirement for bulk fatty acids in barrier homeostasis. Thus, inhibiting the epidermal synthesis of any of the three key lipids that form the extracellular, lipid-enriched membranes of the stratum corneum results in an impairment in barrier homeostasis.

摘要

渗透屏障由神经酰胺、甾醇和游离脂肪酸的混合物介导,它们在角质层中排列成细胞外片层双分子层。尽管先前的研究表明胆固醇和神经酰胺是正常屏障功能所必需的,但非必需脂肪酸重要性的确切证据尚不存在。为了确定表皮脂肪酸合成对于屏障稳态是否也是必需的,我们在通过丙酮或胶带剥离破坏屏障后,应用了5-(十四烷氧基)-2-呋喃羧酸(TOFA),一种乙酰辅酶A羧化酶抑制剂。TOFA可抑制表皮脂肪酸约50%,并显著延迟屏障恢复。此外,将棕榈酸与TOFA共同给药可使屏障恢复正常,表明延迟是由于大量脂肪酸缺乏所致。此外,TOFA处理还会延迟脂质返回角质层,并导致板层小体结构异常,板层小体是将脂质输送到角质层的细胞器。此外,TOFA处理会破坏角质层间隙中分泌的板层小体物质组织成片层双分子层的过程。最后,棕榈酸与TOFA共同应用可纠正板层小体和角质层膜结构的这些异常。这些结果证明了大量脂肪酸对于屏障稳态的必要性。因此,抑制形成角质层富含脂质的细胞外膜的三种关键脂质中任何一种的表皮合成都会导致屏障稳态受损。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0591/294916/1a2ad50f5058/jcinvest00029-0269-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验